Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Capitol Capsule: Will next 4 years mean struggling, juggling, haggling for biopharma?

This article was originally published in Scrip

Executive Summary

With President Barack Obama officially taking the oath of office at the White House on 20 January – with the ceremonial swearing in on 21 January on Capitol Hill – came not only the beginning of his second term, but the continuation of many difficult problems and some expected and likely unforeseen challenges ahead, along with the start of the clock ticking away on his dwindling power in a toxic Washington atmosphere.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC020120

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel